에 대한 최신 뉴스 Solventum (NYSE:SOLV) 주식

Solventum

Solventum is an independent healthcare company with a primary focus on solving big healthcare challenges. Its diverse product portfolio spans across the healthcare industry from medical solutions and oral care to health information systems and separation and purification sciences.

News

Politics

Personal Finance

ARKK

HUMA

INTC

PARA

PARAA

SOLV

SSBK

미국 의회 의원들의 주식 거래 활동은 위원회 임무를 포함한 이해 상충이 거래에 영향을 미칠 수 있다는 가능성으로 인해 투자자들로부터 지속적으로 관심을 끌고 있다. 잘 알려진 한 의회 의원은 금요일 시장 마감 무렵에 여러 거래를 공개했다.

미 상원 의원 토미 튜버빌은 여러 대형주의 매도와 매수 포지션 공개

Solventum Corp

SOLVE

SOLVBL SOLUTIONS INC by SOLVBL SOLUTIONS INC.

SoLVBL Solutions Inc

SOLVAY BANK SOLVAY NY by Solvay Bank (NY)

Solvay Bank

Solvay SA

<p>The larger-than-expected drop in the June Consumer Price Index inflation rate has fueled market expectations for interest rate cuts <a href="https://www.benzinga.com/topic/interest-rates">by the Federal Reserve.</a></p>
<p>Investors no longer seem to have doubts and are assigning a 91% implied probability that rate cuts will begin as early as September 2024.</p>
<p>The upcoming Producer Price Index (PPI) inflation report, scheduled for release on Friday at 8:30 a.m. ET, will be crucial in determining whether producer price trends can continue to support rate-cut expectations or temper the optimism.</p>
<h3 class="wp-block-heading">June PPI Preview: What Economists Expect</h3>
<ul>
<li>Producer prices in June are expected to rise 0.1% on the month versus an unexpected 0.2% decline in May, according to economist consensus estimates, as tracked by TradingEconomics. </li>
<li>On an annual basis, the PPI inflation is expected to accelerate from 2.2% to 2.3%.</li>
<li>Excluding food and energy, core PPI is expected to advance by 0.2% month-over-month, accelerating from the previous flat reading. </li>
<li>Annually, core producer prices are set to rise by 2.5%, up from 2.3% in May. That would mark the highest annual core producer inflation rate since August 2023. </li>
</ul>
<h3 class="wp-block-heading">5 ETFs To Watch Friday</h3>
<p>On Thursday, traders favored markets poised to gain <a href="https://www.benzinga.com/markets/asia/24/07/39733667/inflation-data-sparks-rush-for-gold-real-estate-treasuries-yen-traders-see-september-rate-cut-as-don">from future rate cuts,</a> investing in sectors that could benefit from reduced borrowing costs, while penalizing assets that had already heavily discounted expectations of monetary policy shifts.</p>
<p>The producer inflation data will be pivotal in evaluating if this market momentum will persist. </p>
<p>Among Thursday&#8217;s top-performing exchange-traded funds, we can definitely mention:</p>
<ul>
<li><strong>SPDR Homebuilders ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XHB#NYSE">XHB</a>) rallying 6.1%</li>
<li><strong>Invesco Solar ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAN#NYSE">TAN</a>) rising 4.4%</li>
<li><strong>SPDR S&amp;P Regional Banking ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KRE#NYSE">KRE</a>) up 4.2%</li>
<li><strong>iShares Russell 2000 ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) up 3.6%</li>
<li><strong>VanEck Gold Miners ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GDX#NYSE">GDX</a>) up 2.9%</li>
</ul>
<p>Read now: </p>
<ul>
<li><strong><a href="https://www.benzinga.com/general/politics/24/07/39731800/biden-cheers-inflation-progress-rate-cut-chorus-grows-louder-among-5-economists-this-is-just-wha">Biden Cheers Inflation Progress, Rate Cut Chorus Grows Louder Among 5 Economists: &#8216;This Is Just What The JayMan Needed&#8217;</a></strong></li>
</ul>
<p><em>Image created using artificial intelligence via Midjourney.</em></p>


Equities

Large Cap

Macro Economic Events

Sector ETFs

Econ #s

Economics

Federal Reserve

ETFs

Market Vectors ETF Trust Market Vectors Gold Miners

Could June Producer Inflation Data Dampen Market Enthusiasm For Rate-Cut Winners? 5 ETFs To Watch

<p>Financial giants have made a conspicuous bearish move on Cytokinetics. Our analysis of options history for Cytokinetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYTK#NASDAQ">CYTK</a>) revealed 18 unusual trades.</p>
<p>Delving into the details, we found 16% of traders were bullish, while 66% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $63,000, and 16 were calls, valued at $1,379,080.</p>
<h3>Expected Price Movements</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $35.0 to $75.0 for Cytokinetics over the recent three months. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for Cytokinetics's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Cytokinetics's whale activity within a strike price range from $35.0 to $75.0 in the last 30 days. </p>
<h3>Cytokinetics 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1720729912_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th style="text-align: right;"><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>CYTK</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$24.2</td>
<td>$24.0</td>
<td>$24.0</td>
<td>$35.00</td>
<td>$120.0K</td>
<td style="text-align: right;">801</td>
<td style="text-align: right;">50</td>
</tr>
<tr>
<td>CYTK</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$24.2</td>
<td>$24.0</td>
<td>$24.0</td>
<td>$35.00</td>
<td>$120.0K</td>
<td style="text-align: right;">801</td>
<td style="text-align: right;">550</td>
</tr>
<tr>
<td>CYTK</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$24.2</td>
<td>$24.0</td>
<td>$24.0</td>
<td>$35.00</td>
<td>$120.0K</td>
<td style="text-align: right;">801</td>
<td style="text-align: right;">550</td>
</tr>
<tr>
<td>CYTK</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$24.2</td>
<td>$24.0</td>
<td>$24.0</td>
<td>$35.00</td>
<td>$120.0K</td>
<td style="text-align: right;">801</td>
<td style="text-align: right;">300</td>
</tr>
<tr>
<td>CYTK</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$24.2</td>
<td>$24.0</td>
<td>$24.0</td>
<td>$35.00</td>
<td>$120.0K</td>
<td style="text-align: right;">801</td>
<td style="text-align: right;">300</td>
</tr>
</tbody>
</table>
</p>
<h3>About Cytokinetics</h3>
<p>Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.</p>
<p>Having examined the options trading patterns of Cytokinetics, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Present Market Standing of Cytokinetics</h3>
<ul>
<li>With a volume of 1,441,074, the price of CYTK is up 2.49% at $56.3. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 21 days.</li>
</ul>
<h3>Professional Analyst Ratings for Cytokinetics</h3>
<p>In the last month, 2 experts released ratings on this stock with an average target price of $77.5.</p>
<ul>
<li>Maintaining their stance, an analyst from JP Morgan continues to hold a Overweight rating for Cytokinetics, targeting a price of $65. </li>
<li>In a cautious move, an analyst from HC Wainwright &amp; Co. downgraded its rating to Buy, setting a price target of $90. </li>
</ul>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Cytokinetics, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Options

Markets

CYTK

A Closer Look at Cytokinetics's Options Market Dynamics

<p>Deep-pocketed investors have adopted a bullish approach towards D.R. Horton (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHI#NYSE">DHI</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in DHI usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 30 extraordinary options activities for D.R. Horton. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 43% leaning bullish and 33% bearish. Among these notable options, 8 are puts, totaling $284,454, and 22 are calls, amounting to $1,811,598.</p>
<h3>Predicted Price Range</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $110.0 to $165.0 for D.R. Horton during the past quarter. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for D.R. Horton's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of D.R. Horton's whale trades within a strike price range from $110.0 to $165.0 in the last 30 days. </p>
<h3>D.R. Horton Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1720729908_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>DHI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/19/24</td>
<td>$10.2</td>
<td>$9.1</td>
<td>$9.8</td>
<td>$140.00</td>
<td>$784.0K</td>
<td>1.7K</td>
<td style="text-align: right;">161</td>
</tr>
<tr>
<td>DHI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$8.0</td>
<td>$7.6</td>
<td>$7.87</td>
<td>$160.00</td>
<td>$103.5K</td>
<td>506</td>
<td style="text-align: right;">2</td>
</tr>
<tr>
<td>DHI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>11/15/24</td>
<td>$8.9</td>
<td>$8.6</td>
<td>$8.7</td>
<td>$155.00</td>
<td>$93.3K</td>
<td>195</td>
<td style="text-align: right;">19</td>
</tr>
<tr>
<td>DHI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$12.5</td>
<td>$11.5</td>
<td>$12.49</td>
<td>$145.00</td>
<td>$90.3K</td>
<td>94</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>DHI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/26/24</td>
<td>$6.7</td>
<td>$6.4</td>
<td>$6.5</td>
<td>$147.00</td>
<td>$65.0K</td>
<td>0</td>
<td style="text-align: right;">100</td>
</tr>
</tbody>
</table>
</p>
<h3>About D.R. Horton</h3>
<p>D.R. Horton is a leading homebuilder in the United States with operations in 118 markets across 33 states. D.R. Horton mainly builds single-family detached homes (over 90% of home sales revenue) and offers products to entry-level, move-up, luxury buyers, and active adults. The company offers homebuyers mortgage financing and title agency services through its financial services segment. D.R. Horton's headquarters are in Arlington, Texas, and it manages six regional segments across the United States.</p>
<h3>D.R. Horton's Current Market Status</h3>
<ul>
<li>Trading volume stands at 4,529,163, with DHI's price up by 7.26%, positioned at $149.73.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 7 days.</li>
</ul>
<h3>Expert Opinions on D.R. Horton</h3>
<p>A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $156.0.</p>
<ul>
<li>An analyst from Citigroup has revised its rating downward to Neutral, adjusting the price target to $156. </li>
</ul>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for D.R. Horton, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


D.R. Horton's Options: A Look at What the Big Money is Thinking

<p><strong>George R.R. Martin </strong>has revealed a striking set of new covers for his epic fantasy series, A Song of Ice and Fire. </p>
<p>The announcement, made via Martin&#8217;s <a href="https://georgerrmartin.com/notablog/2024/07/10/a-bold-new-look-for-the-a-song-of-ice-and-fire-boxed-set/">blog,</a> &#8220;Not a Blog,&#8221; showcases a collection of artwork that promises to redefine the visual identity of this beloved saga.</p>
<p><strong>See Also: <a href="https://www.benzinga.com/general/entertainment/24/07/39579853/george-r-r-martin-fuels-rumors-about-elden-ring-movie-or-tv-show">George R. R. Martin Fuels Rumors About Elden Ring Movie Or TV Show</a></strong></p>
<p>The new covers, set to grace both individual volumes and a boxed set of the entire series, feature artwork crafted using traditional linocut and woodcut techniques.</p>
<p>According to the post, the designs were brought to life through the collaborative efforts of linocut artist <strong>Mark Seekins</strong>, designer <strong>Tim Green</strong>, and art director <strong>David G. Stevenson</strong>. </p>
<p>The process involved meticulous sketching, carving intricate designs into linoleum blocks, and layering multiple colors to achieve a rich, textured effect.</p>
<p>&#8220;There is a raw and gritty quality to linocut and woodcut art,&#8221; Martin&#8217;s blog post explained, &#8220;A certain starkness that seemed to fit the stories, and a long history to the art form that felt right for this world.&#8221;</p>
<h3 class="wp-block-heading"><strong>Introducing New &#8216;Song of Ice And Fire&#8217; Covers</strong></h3>
<p>The unveiling of these covers marks a significant moment for fans, who can expect to find the boxed set available online and in stores starting October 2024. However, specific pricing details have yet to be disclosed.</p>
<p>Meanwhile, despite the excitement surrounding this visual refresh, Martin&#8217;s announcement inevitably raises questions about the progress of the series&#8217; eagerly anticipated next installment, The Winds of Winter. </p>
<p>Originally slated for completion years ago, the novel remains a work in progress, with Martin acknowledging the challenges of bringing the intricate narrative to a satisfying conclusion.</p>
<p>&#8220;No writer is blessed with producing a perfect first draft,&#8221; Martin commented in his blog, addressing the ongoing saga of The Winds of Winter&#8217;s development. Despite having reportedly written 1,100 pages of the novel as of November 2023, he admits the meticulous process of revision and refinement continues.</p>
<h3 class="wp-block-heading"><strong>Here Are Some Of R. R. Martin&#8217;s New Covers: </strong></h3>
<p><figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="678" height="1024" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/11150225/agameofthrones_2024_tr_repackage-768x1160-1-678x1024.jpeg" alt="" class="wp-image-431887" style="width:365px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/11150225/agameofthrones_2024_tr_repackage-768x1160-1-678x1024.jpeg 678w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/11150225/agameofthrones_2024_tr_repackage-768x1160-1-199x300.jpeg 199w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/11150225/agameofthrones_2024_tr_repackage-768x1160-1.jpeg 715w" sizes="(max-width: 678px) 100vw, 678px" /><figcaption class="wp-element-caption">Image Credit: George R.R. Martin &#8211; Not a Blog</figcaption></figure></p>
<p><figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="678" height="1024" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/11150836/aclashofkings_2024_tr_repackage-768x1160-1-678x1024.jpeg" alt="" class="wp-image-431902" style="width:358px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/11150836/aclashofkings_2024_tr_repackage-768x1160-1-678x1024.jpeg 678w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/11150836/aclashofkings_2024_tr_repackage-768x1160-1-199x300.jpeg 199w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/11150836/aclashofkings_2024_tr_repackage-768x1160-1.jpeg 715w" sizes="(max-width: 678px) 100vw, 678px" /><figcaption class="wp-element-caption">Image Credit: George R.R. Martin &#8211; Not a Blog</figcaption></figure></p>
<p><figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="678" height="1024" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/11150951/astormofswords_2024_tr_repackage-768x1160-1-678x1024.jpeg" alt="" class="wp-image-431904" style="width:359px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/11150951/astormofswords_2024_tr_repackage-768x1160-1-678x1024.jpeg 678w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/11150951/astormofswords_2024_tr_repackage-768x1160-1-199x300.jpeg 199w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/11150951/astormofswords_2024_tr_repackage-768x1160-1.jpeg 715w" sizes="(max-width: 678px) 100vw, 678px" /><figcaption class="wp-element-caption">Image Credit: George R.R. Martin &#8211; Not a Blog</figcaption></figure></p>
<p><strong>Read Next: </strong></p>
<ul>
<li><a href="https://www.benzinga.com/general/entertainment/24/01/36598447/game-of-thrones-creators-spill-secrets-on-axed-star-wars-project-we-werent-the-droids-they-"><strong>&#8216;Game Of Thrones&#8217; Creators Spill Secrets On Axed &#8216;Star Wars&#8217; Project: &#8216;We Weren&#8217;t The Droids They Were Looking For&#8217;</strong></a></li>
</ul>
<p><em>Image credits: Shutterstock.</em></p>


Entertainment

General

Check Out George R.R. Martin's Stunning New 'Game Of Thrones' Covers: 'Raw And Gritty Quality — Right For This World'

<p>Mastercard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>) has outperformed the market over the past 15 years by 11.11% on an annualized basis producing an average annual return of 23.69%. Currently, Mastercard has a market capitalization of $408.30 billion. </p>
<p><strong>Buying $1000 In MA:</strong> If an investor had bought $1000 of MA stock 15 years ago, it would be worth <strong>$24,480.84</strong> today based on a price of $439.22 for MA at the time of writing.</p>
<h3>Mastercard's Performance Over Last 15 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1720729904_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Trading Ideas

If You Invested $1000 In This Stock 15 Years Ago, You Would Have $24,000 Today

<p>High-rolling investors have positioned themselves bearish on PENN Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PENN#NASDAQ">PENN</a>), and it's important for retail traders to take note.<br />
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in PENN often signals that someone has privileged information.</p>
<p>Today, Benzinga's options scanner spotted 14 options trades for PENN Entertainment. This is not a typical pattern.</p>
<p>The sentiment among these major traders is split, with 35% bullish and 57% bearish. Among all the options we identified, there was one put, amounting to $40,086, and 13 calls, totaling $672,415.</p>
<h3>Projected Price Targets</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $15.0 to $25.0 for PENN Entertainment over the recent three months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in PENN Entertainment's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to PENN Entertainment's substantial trades, within a strike price spectrum from $15.0 to $25.0 over the preceding 30 days.</p>
<h3>PENN Entertainment Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1720729902_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>PENN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$7.3</td>
<td>$6.95</td>
<td>$6.95</td>
<td>$15.00</td>
<td>$161.9K</td>
<td>1.1K</td>
<td style="text-align: right;">567</td>
</tr>
<tr>
<td>PENN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$7.0</td>
<td>$6.9</td>
<td>$6.9</td>
<td>$15.00</td>
<td>$104.2K</td>
<td>1.1K</td>
<td style="text-align: right;">335</td>
</tr>
<tr>
<td>PENN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$6.8</td>
<td>$6.75</td>
<td>$6.8</td>
<td>$15.00</td>
<td>$70.7K</td>
<td>1.1K</td>
<td style="text-align: right;">160</td>
</tr>
<tr>
<td>PENN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$2.95</td>
<td>$2.89</td>
<td>$2.9</td>
<td>$20.00</td>
<td>$43.5K</td>
<td>19.0K</td>
<td style="text-align: right;">27</td>
</tr>
<tr>
<td>PENN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$1.98</td>
<td>$1.96</td>
<td>$1.97</td>
<td>$20.00</td>
<td>$40.0K</td>
<td>1.0K</td>
<td style="text-align: right;">91</td>
</tr>
</tbody>
</table>
</p>
<h3>About PENN Entertainment</h3>
<p>Penn Entertainment's origins date back to its 1972 racetrack opening in Pennsylvania. Today, Penn operates 43 properties across 20 states and 12 brands, including Hollywood Casino and Ameristar. Land-based casinos represented 89% of total sales in 2023; 11% was from the interactive segment, which includes sports, iGaming, and media revenue. The retail portfolio generates mid-30s EBITDAR margins and helps position the company to obtain licenses for the digital wagering markets. Additionally, Penn's media assets, theScore and ESPN (starting with its partnership launch in November 2023), provide access to sports betting/iGaming technology and clientele, helping it form a leading digital position.</p>
<p>In light of the recent options history for PENN Entertainment, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Present Market Standing of PENN Entertainment</h3>
<ul>
<li>Currently trading with a volume of 8,170,710, the PENN's price is up by 3.49%, now at $20.77. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 28 days.</li>
</ul>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest PENN Entertainment options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


PENN

Market Whales and Their Recent Bets on PENN Options

<p>Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) has outperformed the market over the past 10 years by 9.29% on an annualized basis producing an average annual return of 20.18%. Currently, Alphabet has a market capitalization of $2.30 trillion. </p>
<p><strong>Buying $1000 In GOOGL:</strong> If an investor had bought $1000 of GOOGL stock 10 years ago, it would be worth <strong>$6,258.05</strong> today based on a price of $186.06 for GOOGL at the time of writing.</p>
<h3>Alphabet's Performance Over Last 10 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1720729899_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


GOOGL

$1000 Invested In Alphabet 10 Years Ago Would Be Worth This Much Today

<p>The Company is working diligently and expects to file its Form 10-Q within the next three weeks, which would eliminate the need for the Company to submit a formal plan to regain compliance.</p>


QOMO

Qomolangma Acquisition Receives Notice From Nasdaq Regarding Not Filing Quarterly Report

Insider Trades

NVDA

NVIDIA Director Mark A. Stevens Sells 785K Shares At Average Price Of $132.48

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/AUSAF"><strong>Australis Capital</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/AUSAF#OTC">AUSAF</a>) shares closed up 9900.00% at $0.0001</li>
<li><a href="https://www.benzinga.com/quote/CARA"><strong>Cara Therapeutics</strong></a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARA#NASDAQ">CARA</a>) shares closed up 25.84% at $0.37</li>
<li><a href="https://www.benzinga.com/quote/FFNTF"><strong>4Front Ventures</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed up 23.42% at $0.10</li>
<li><a href="https://www.benzinga.com/quote/BLOZF"><strong>Cannabix Technologies</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BLOZF#OTC">BLOZF</a>) shares closed up 15.92% at $0.43</li>
<li><a href="https://www.benzinga.com/quote/FUAPF"><strong>Global Compliance</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FUAPF#OTC">FUAPF</a>) shares closed up 12.75% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/XXII"><strong>22nd Century Group</strong></a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares closed up 11.92% at $0.79</li>
<li><a href="https://www.benzinga.com/quote/CURLF"><strong>Curaleaf Holdings</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>) shares closed up 9.71% at $4.18</li>
<li><a href="https://www.benzinga.com/quote/SOLCF"><strong>SOL Glb Inv</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed up 9.05% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/OGI"><strong>OrganiGram Holdings</strong></a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>) shares closed up 7.59% at $1.70</li>
<li><a href="https://www.benzinga.com/quote/CNPOF"><strong>RIV Capital</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNPOF#OTC">CNPOF</a>) shares closed up 7.14% at $0.10</li>
<li><a href="https://www.benzinga.com/quote/GRWG"><strong>GrowGeneration</strong></a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) shares closed up 6.82% at $2.35</li>
<li><a href="https://www.benzinga.com/quote/ACB"><strong>Aurora Cannabis</strong></a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) shares closed up 6.68% at $6.12</li>
<li><a href="https://www.benzinga.com/quote/SNDL"><strong>SNDL</strong></a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDL#NASDAQ">SNDL</a>) shares closed up 6.37% at $2.18</li>
<li><a href="https://www.benzinga.com/quote/EAST"><strong>Eastside Distilling</strong></a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EAST#NASDAQ">EAST</a>) shares closed up 6.33% at $1.19</li>
<li><a href="https://www.benzinga.com/quote/GTBIF"><strong>Green Thumb Industries</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTC">GTBIF</a>) shares closed up 5.04% at $11.87</li>
<li><a href="https://www.benzinga.com/quote/CRLBF"><strong>Cresco Labs</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>) shares closed up 5.03% at $1.67</li>
<li><a href="https://www.benzinga.com/quote/CXXIF"><strong>C21 Investments</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>) shares closed up 4.35% at $0.25</li>
<li><a href="https://www.benzinga.com/quote/CNBX"><strong>CNBX Pharmaceuticals</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed up 4.23% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/SMG"><strong>Scotts Miracle Gro</strong></a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) shares closed up 4.18% at $63.85</li>
<li><a href="https://www.benzinga.com/quote/ESE"><strong>ESCO Technologies</strong></a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESE#NYSE">ESE</a>) shares closed up 4.13% at $114.00</li>
<li><a href="https://www.benzinga.com/quote/BMMJ"><strong>Body and Mind</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BMMJ#OTC">BMMJ</a>) shares closed up 3.60% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/CRBP"><strong>Corbus Pharmaceuticals</strong></a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) shares closed up 3.59% at $53.34</li>
<li><a href="https://www.benzinga.com/quote/VFF"><strong>Village Farms Intl</strong></a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) shares closed up 3.33% at $1.00</li>
<li><a href="https://www.benzinga.com/quote/CBWTF"><strong>Auxly Cannabis Group</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBWTF#OTC">CBWTF</a>) shares closed up 3.17% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/SOL"><strong>Emeren Group</strong></a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) shares closed up 3.11% at $1.76</li>
<li><a href="https://www.benzinga.com/quote/CRON"><strong>Cronos Group</strong></a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRON#NASDAQ">CRON</a>) shares closed up 3.03% at $2.38</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/LMLLF"><strong>Pharmadrug</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LMLLF#OTC">LMLLF</a>) shares closed down 67.22% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/LVRLF"><strong>CordovaCann</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LVRLF#OTC">LVRLF</a>) shares closed down 55.65% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/CNGGF"><strong>Cann Gr</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNGGF#OTC">CNGGF</a>) shares closed down 35.20% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CBDY"><strong>Target Group</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBDY#OTC">CBDY</a>) shares closed down 33.52% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/RSSFF"><strong>Affinor Growers</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RSSFF#OTC">RSSFF</a>) shares closed down 21.64% at $0.07</li>
<li><a href="https://www.benzinga.com/quote/RMHB"><strong>Rocky Mountain High</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed down 12.73% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/ITHUF"><strong>iAnthus Capital Hldgs</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ITHUF#OTC">ITHUF</a>) shares closed down 7.65% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/MRMD"><strong>MariMed</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#OTC">MRMD</a>) shares closed down 7.43% at $0.16</li>
<li><a href="https://www.benzinga.com/quote/MGWFF"><strong>Maple Leaf Green World</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MGWFF#OTC">MGWFF</a>) shares closed down 7.41% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/NWVCF"><strong>EnWave</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed down 5.06% at $0.17</li>
<li><a href="https://www.benzinga.com/quote/UGRO"><strong>Urban-gro</strong></a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) shares closed down 3.95% at $1.46</li>
<li><a href="https://www.benzinga.com/quote/YCBD"><strong>cbdMD</strong></a> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) shares closed down 3.23% at $0.57</li>
</ul>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Cannabis

Movers

AUSAF

BLOZF

BMMJ

CARA

CBDY

CANNABIS WHEATON INCOME by Cannabis Wheaton Income Corp.

CBWTF

CNBX

CNGGF

CNPOF

CRBP

CRLBF

CRON

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

CXXIF

EAST

FFNTF

FUAPF

GRWG

GTBIF

ITHUF

LMLLF

LVRLF

MGWFF

MRMD

NWVCF

RMHB

RSSFF

SNDL

SOLCF

UGRO

XXII

YCBD

Marijuana Stock Movers For July 11, 2024

<p><strong><em>By <a href="https://elplanteo.com/author/lucia-tedesco/" target="_blank" rel="noreferrer noopener">Lucía Tedesco</a> via <a href="https://elplanteo.com/marihuana-argentina-exporta-europa/" target="_blank" rel="noreferrer noopener">El Planteo</a></em></strong></p>
<p>The Argentine, state-owned company, <strong><a href="https://elplanteo.com/cannava-cannabis-empresa-jujuy/">Cannava</a>,</strong> has successfully completed its first export of cannabis flowers to Europe and Australia. This milestone is the result of six years of research, development and production efforts to establish the province of Jujuy as a leader in the export of pharmaceutical-grade cannabis.</p>
<p>Under the direction of <strong>Gastón Morales,</strong> the Jujuy-based company has secured contracts to ship cannabis flower to Germany, Portugal and Australia. These flowers, with high THC content (ranging from 20% to 27%), are exclusively for therapeutic use. &#8220;Based on these contracts alone, we have received purchase orders for 730 kilograms of flowers for three destinations, representing an annual revenue of EUR 5 million ($5.4 million),&#8221; Morales told Infobae.</p>
<h3 class="wp-block-heading">The Economic Impact Of Argentine Marijuana</h3>
<p>The international advance in the use of medicinal cannabis is coupled with a significant economic impact on the province of Jujuy. Revenue is expected to grow to EUR 7.6 million in the second year, &#8220;with sustained demand growth of 5% annually,&#8221; Morales noted.</p>
<p>In 2023, a team from Cannava traveled to Switzerland and Germany to present its work at the Finca El Pongo. The team was &#8220;assisted by the embassy in Germany, which facilitated a series of meetings with European companies,&#8221; according to the company&#8217;s director. These commercial alliances secured long-term supply contracts for the organization.</p>
<p>This year, Cannava solidified its presence in Australia by signing a contract with <strong>Cannabas PTY,</strong> securing orders of 1,250 kilograms in the first year and 2,500 kilograms in the second. Australia&#8217;s regulatory model allows the sale of cannabis flower in authorized pharmacies. However, due to limited local production, Australia has become a key market for cannabis imports.</p>
<p>Morales announced that in November, a call for private-sector cannabis ventures will be launched, aiming to create a public-private production system that further strengthens the industry.</p>
<h3 class="wp-block-heading">Regulatory Challenges For Cannabis in Argentina</h3>
<p>Nonetheless, cannabis in Argentina is facing several regulatory challenges. Law 27.669 has not been fully implemented, the Regulatory Agency for Cannabis Research and Medicinal Derivatives (Ariccame) has been without appointments for seven months and delays in the patient registry (Reprocann) persist. If the future of cannabis in Argentina is so promising, why is it still challenging to recognize society&#8217;s right to this crucial plant for the international market?</p>
<p><em>This article is from an external unpaid contributor. It does not represent Benzinga&#8217;s reporting and has not been edited for content or accuracy.</em></p>


Govt-Owned Cannabis Company Exports Flower From Argentina To EU, Australia, Secures Purchase Orders Worth Millions

Offerings

AVTX

Avalo Therapeutics Announces Prospectus For Sale Of Up To 22.4M Shares Of Common Stock And Series C Preferred Stock, Plus 12M Warrants By Selling Stockholders

<p>The whiskey industry is witnessing increased diversity and enhanced quality, particularly attributed to independent bottlers <a href="https://www.benzinga.com/money/how-to-invest-in-whiskey">like The Single Cask</a>. </p>
<p>These entities are instrumental in introducing distinct, single-cask whiskeys to the market, offering consumers a wide range of flavors and profiles often not available from mainstream distilleries.</p>
<h3 class="wp-block-heading">The Role of Independent Bottlers</h3>
<p><strong>Vincent Flint-Hill</strong>, representing <strong>The Single Cask</strong>, shared insights during Benzinga's recent <strong><a href="https://www.benzinga.com/events/">whiskey investing webinar</a></strong>. Flint-Hill emphasized the independent bottlers&#8217; mission to identify exceptional single casks and present them to the market as unique representations of their distilleries. </p>
<p>&#8220;Our job is to sort of find single cask whiskeys that are quite special and bring them into the market as a single cask snapshot of that distillery,&#8221; he explained. Independent bottlers set themselves apart by focusing on lesser-known distilleries and unique cask finishes, thereby broadening the market and educating consumers about the diverse range of whiskey profiles.</p>
<h3 class="wp-block-heading">Consumer Benefits</h3>
<p>The meticulous attention given to each cask ensures high-quality whiskey. Flint-Hill says their rigorous process: &#8220;Every cask sits on its own. We can actually go and see and touch and look at the end of every single cask. What it means is every week, we can do a walk around, and we can actually look for, you know, can we see drips on casks? Can we see this?&#8221;</p>
<p>This hands-on approach allows independent bottlers to address any potential issues early, maintaining the whiskey&#8217;s integrity. This dedication to quality control is a major benefit for consumers, who can trust that each bottle represents the best possible version of the whiskey.</p>
<h3 class="wp-block-heading">Expanding Market Reach</h3>
<p>Independent bottlers also contribute to market expansion by making high-quality whiskey accessible to more regions. Flint-Hill mentioned a regulatory change that opened new opportunities for the American market: &#8220;There was a big change, especially for Scotch, with the 750 ml regulations changing a couple of years ago for the USA. What it means now is that independent bottlers such as ourselves if we bottle one cask and we get 300 bottles out of it, we would only typically do 700 ml. We didn&#8217;t have access to America before unless you were doing specific 750 ml bottles.&#8221;</p>
<p>This regulatory shift allows independent bottlers to serve the largest whiskey market in the world, increasing their reach and influence. By offering unique products in new markets, these bottlers are enriching the global whiskey scene with diverse and high-quality offerings.</p>
<h3 class="wp-block-heading">Industry Impact</h3>
<p>The contributions of independent bottlers like The Single Cask are reshaping the whiskey industry, providing consumers with an array of options and enhancing the overall quality of available products. Their efforts in identifying, preserving, and marketing exceptional single casks are helping to set new standards in the industry.</p>
<hr class="wp-block-separator has-alpha-channel-opacity" />
<p><em>Make sure to mark your calendars for&nbsp;<a href="https://www.benzinga.com/events/" target="_blank" rel="noreferrer noopener">Benzinga's upcoming virtual events</a>. These sessions are designed to educate and engage a diverse audience of traders, investors, and financial professionals. Featuring thought leaders and industry experts, Benzinga's webinars offer timely, actionable insights to help you navigate the ever-changing market landscape. From whiskey investing to groundbreaking startups and real estate trends, there&#8217;s something for everyone. Don't miss the opportunity to gain valuable knowledge and stay ahead in your field.&nbsp;<a href="https://www.benzinga.com/events/" target="_blank" rel="noreferrer noopener">Learn more here.</a></em></p>
<p><em>Image: Shutterstock</em></p>


Retail Sales

Events

Exclusives

Media

Whiskey's Best Kept Secret: Independent Bottlers Bring New Flavors To Market

<p>DHT Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHT#NYSE">DHT</a>) ("DHT" or the "Company") today provides the following business update:</p>
<p>For the second quarter of 2024, the Company estimates time charter equivalent earnings for its fleet at $49,100 per day, comprising of $52,700 per day for the Company's VLCCs operating in the spot market and $36,400 per day for the Company's VLCCs on time-charter. The estimated time charter equivalent earnings are based on 2,114 revenue days for the second quarter, of which 1,644 days are spot days.</p>
<p>Thus far in the third quarter of 2024, 48% of the available spot days have been booked at an average rate of $45,600 per day on a discharge-to-discharge basis. 61% of the available revenue days, spot and time-charter days combined, have been booked at an average rate of $42,300 per day.</p>
<p>In the second quarter of 2024, the Company entered into a one-year time charter contract with a refining company for DHT Europe, built 2007. The time charter contract has a rate of $49,500 per day and the vessel is intended to trade in the Atlantic basin, servicing a European refinery.</p>
<p>As previously announced, the Company has entered into agreements to build four large VLCCs with originally expected delivery between April and December 2026. The expected delivery has been expedited, hence increasing revenue days in 2026. We expect the first vessel to be delivered in February, the second vessel in April, the third vessel in May and the fourth and final vessel is expected to be delivered in July 2026.</p>


Contracts

DHT Holdings Says Thus Far In Q3 2024, 48% Of The Available Spot Days Have Been Booked At An Average Rate Of $45,600 Per Day On A Discharge-To-Discharge Basis; Provides Business Update

<p>Cryptocurrency markets are trading relatively flat despite positive macroeconomic data fueling hopes of a September <a href="https://www.benzinga.com/news/large-cap/24/07/39736302/tech-stocks-tumble-as-small-caps-reits-gold-miners-rally-soft-june-inflation-ignites-rate-cut-expe">interest rate cut</a>.</p>
<p><figure class="wp-block-table"><br />
<table>
<tbody>
<tr>
<td><strong>Cryptocurrency</strong></td>
<td><strong>Price</strong></td>
<td><strong>Gains +/-</strong></td>
</tr>
<tr>
<td><strong>Bitcoin</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>$57,371.10&nbsp;</td>
<td>-0.09%</td>
</tr>
<tr>
<td><strong>Ethereum</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>$3,107.17</td>
<td>-0.05%</td>
</tr>
<tr>
<td><strong>Solana</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>$136.57</td>
<td>-3.3%</td>
</tr>
<tr>
<td><strong>Dogecoin </strong>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.1071</td>
<td>-0.8%</td>
</tr>
<tr>
<td><strong>Shiba Inu</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>$0.0000164&nbsp;&nbsp;</td>
<td>+0.35</td>
</tr>
</tbody>
</table>
<p></p></figure></p>
<p><strong>Notable Statistics:</strong></p>
<ul>
<li>IntoTheBlock data notes a 79.8% increase in exchange netflows, while daily activity addresses rose by 4.2%. Transactions greater than $100,000 increased from 7,269 to 8,500 in a single day.</li>
<li>Coinglass data notes 38,109 traders liquidated for $104.46 million over the past 24 hours.</li>
<li>Sentiment <a href="https://x.com/santimentfeed/status/1811199249776074985">data</a> shows that during the current downtrend, Bitcoin whale and shark wallets are increasing while small traders sell off their bags. It highlighted a net increase of +261 wallets that now hold at least 10 BTC.</li>
<li>The German government's Bitcoin is running out as it sent another 5,000 BTC to Flow Traders, Coinbase, Kraken, Bitstamp, 139Po, and bc1qu.</li>
</ul>
<p><strong>Notable Developments:</strong></p>
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39736733/sec-ends-investigation-into-paxos-marking-win-for-crypto-industry">SEC Ends Investigation Into Paxos, Marking Win For Crypto Industry</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39734316/bitcoin-option-traders-expect-near-term-volatility-qcp-capital">Bitcoin Option Traders Expect Near-Term Volatility, Crypto-Asset Trading Experts Say</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39736579/crypto-markets-entangled-with-100b-in-illicit-funds-since-2019-report">Crypto Markets Entangled With $100B In Illicit Funds Since 2019: Report</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39733359/bitcoin-mining-stocks-marathon-digital-cleanspark-and-riot-platforms-are-rising-whats-goin">Bitcoin Mining Stocks Marathon Digital, CleanSpark And Riot Platforms Are Rising: What&#8217;s Going On?</a></li>
<li><a href="https://www.benzinga.com/24/07/39730197/bitcoin-development-company-microstrategy-announces-10-for-1-stock-split">&#8216;Bitcoin Development Company&#8217; MicroStrategy Announces 10-For-1 Stock Split</a></li>
</ul>
<p><figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/"><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/27091545/Benzinga-conference.gif" alt="Benzinga future of digital assets conference" class="wp-image-267246" /></a></figure></p>
<h3 class="wp-block-heading"><strong>Top Gainers:</strong></h3>
<p><figure class="wp-block-table"><br />
<table>
<tbody>
<tr>
<td><strong>Cryptocurrency</strong></td>
<td><strong>Price</strong></td>
<td><strong>Gains +/</strong>–</td>
</tr>
<tr>
<td>MANTRA (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/om/usd">OM</a>)</td>
<td>$1.07</td>
<td>+13%</td>
</tr>
<tr>
<td>Stacks (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/stx/usd">STX</a>)</td>
<td>$1.61</td>
<td>+6.4%</td>
</tr>
<tr>
<td>NEAR Protocol (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/near/usd">NEAR</a>)</td>
<td>$4.94</td>
<td>+6.3%</td>
</tr>
</tbody>
</table>
<p><figcaption class="wp-element-caption"><br /><strong>Trader Notes:</strong> Crypto trader <strong>Poseidon</strong> noted that Bitcoin's daily chart is still bearish and price is below range low. He suggested two scenarios for traders:</figcaption></p></figure></p>
<p><figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"><br />
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><p lang="en" dir="ltr"><a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> Daily <br /><br />Daily trend is still bearish and price is below range low. If you want to take risk for upside, wait for clean range low and daily ema21 reclaim. If you already over exposed, no need to add more risk here, wait for lower prices or trend reclaim. <a href="https://t.co/LzNlOMnZoy">pic.twitter.com/LzNlOMnZoy</a></p>
<p>&mdash; Poseidon (@CryptoPoseidonn) <a href="https://twitter.com/CryptoPoseidonn/status/1811481452258734344?ref_src=twsrc%5Etfw">July 11, 2024</a></p></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<p><figcaption class="wp-element-caption"><strong>Stockmoney Lizards</strong> <a href="https://x.com/StockmoneyL/status/1811461100581368164">predicted</a> that current market cycle could peak around $250,000 to $300,000. He added that this is "NOT a short-term chart. Next weeks might be sideways / down 10 &#8211; 15%." Post the CPI data, the trader <a href="https://x.com/StockmoneyL/status/1811429415341203480">reiterated</a> the same outlook but added an end-of-year prediction of $100,000.<br /><br />Another crypto trader noted that if Bitcoin wants to rally to $60,600 going into the weekend, it will need a daily close "above the black resistance to invalidate the early-stage lower high and set price up for that rally."</figcaption></p></figure></p>
<p><figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"><br />
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><p lang="en" dir="ltr"><a href="https://twitter.com/hashtag/BTC?src=hash&amp;ref_src=twsrc%5Etfw">#BTC</a> <br /><br />Not only is Bitcoin rejecting from the Daily resistance of $58350 (black) but a new Lower High (orange) may also be developing<br /><br />This is not conclusive but if Bitcoin wants to rally to $60600 (blue) going into the weekend&#8230;<br /><br />Bitcoin will need to Daily Close above the black… <a href="https://t.co/tKhGemC8TN">https://t.co/tKhGemC8TN</a> <a href="https://t.co/DOsJ4TNa0W">pic.twitter.com/DOsJ4TNa0W</a></p>
<p>&mdash; Rekt Capital (@rektcapital) <a href="https://twitter.com/rektcapital/status/1811464735377780985?ref_src=twsrc%5Etfw">July 11, 2024</a></p></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<p></p></figure></p>
<p><strong>Read Next:</strong></p>
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39738170/is-a-bitcoin-pump-imminent-this-indicator-says-yes"><strong>Is A Bitcoin Pump Imminent? This Indicator Says Yes</strong></a></li>
</ul>
<p><em>Image: Shutterstock</em></p>


Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$DOGE

$ETH

$JASMY

$NEAR

$ORDI

$SHIB

$SOL

$STX

$UNI

Bitcoin, Ethereum, Dogecoin Consolidate: 'No Need To Add More Risk Here,' Trader Warns

<p>In 2024, the share prices of large-cap companies have soared while small-caps have struggled. Thursday&#8217;s price action could mark a key reversal in <a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/24/07/39673296/just-17-of-s-p-500-stocks-outperform-the-index-what-does-that-mean-for-the-market">this year&#8217;s trend</a>.</p>
<p><strong>Price Action:</strong> The <strong>iShares Russell 2000 ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>), which tracks small-cap stocks, closed up 3.63% on the day. The <strong>iShares Russell 1000 ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWB#NYSE">IWB</a>), which tracks large-cap stocks, was down 0.66% on the day.</p>
<p>The difference between the two indexes&#8217; performances was therefore over 4%.</p>
<p>The <strong>Roundhill Magnificent Seven ETF</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAGS#NASDAQ">MAGS</a>), which tracks <strong>Microsoft Corp,</strong> <strong>Apple Inc</strong>, <strong>NVIDIA Corp</strong>, <strong>Alphabet Inc</strong>, <strong>Meta Platforms Inc</strong>, <strong>Amazon.com Inc</strong> and <strong>Tesla Inc, </strong>saw a big down day. The share prices of the Magnificent Seven collectively fell 4.49%.</p>
<p><strong>Why it Matters:</strong> According to a <a href="https://x.com/edclissold/status/1811426303750643828">post</a> on X by strategist <strong>Ed Clissold</strong>, the Russell 2000 posted one of its best days ever compared to the Russell 1000 on Thursday. A difference between the two indexes of over 4% has only occurred on four occasions:</p>
<ul>
<li>On Oct. 19, 1987, &#8220;Black Monday.&#8221;</li>
<li>On Oct. 10, 2008, during the Great Recession.</li>
<li>On Oct. 4, 2011, following a market low during the European debt crisis.</li>
<li>And on March 19, 2020, near the bottom of a pandemic-driven low.</li>
</ul>
<p><figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"><br />
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><p lang="en" dir="ltr">FWIW, here are Russell 2000/1000 ratio returns after the previous 4 cases. Mixed bag. 2/2 <a href="https://t.co/fXKeKtm61t">pic.twitter.com/fXKeKtm61t</a></p>
<p>&mdash; Ed Clissold (@edclissold) <a href="https://twitter.com/edclissold/status/1811426470499319950?ref_src=twsrc%5Etfw">July 11, 2024</a></p></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<p></p></figure></p>
<p>All of the dates mentioned above occurred during periods of decline; the latest addition to the list is an outlier, as the S&amp;P 500 index is near an all-time high. Alternatively, Thursday&#8217;s results could suggest outcomes similar to historical performance following 4% days.</p>
<p>Small caps seemingly benefited from Thursday&#8217;s <a href="https://www.benzinga.com/economics/macro-economic-events/24/07/39728268/inflation-slows-more-expected-to-3-in-june-heightens-expectations-for-rate-cuts-t">cooler-than-expected</a> June consumer inflation report, which could play a part in preempting interest rate cuts later this year. The higher-for-longer interest rate environment <a href="https://www.benzinga.com/news/24/05/39013274/newedge-wealths-cameron-dawson-talks-prolonged-high-interest-rates-on-premarket-prep">benefitted large-cap</a> companies with extensive cash piles and hurt smaller businesses reliant on debt.</p>
<p><strong>Also Read: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/markets/asia/24/07/39733667/inflation-data-sparks-rush-for-gold-real-estate-treasuries-yen-traders-see-september-rate-cut-as-don">Inflation Data Sparks Rush For Gold, Real Estate, Treasuries, Yen: Traders See September Rate Cut As Done Deal</a></strong></li>
</ul>


Analyst Color

Broad U.S. Equity ETFs

MAGS

The Market Did Something Thursday That Has Only Occurred 4 Times In History

<p>Educational Development (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EDUC#NASDAQ">EDUC</a>) reported quarterly losses of $(0.15) per share. This is a 36.36 percent decrease over losses of $(0.11) per share from the same period last year.  The company reported $9.99 million in sales this quarter. This is a 31.20 percent decrease over sales of $14.52 million the same period last year.</p>


Earnings

EDUC

Educational Development Q1 EPS $(0.15) Down From $(0.11) YoY, Sales $9.99M Down From $14.52M YoY

<p>Vista Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIST#NYSE">VIST</a>) reported quarterly sales of $396.70 million which missed the analyst consensus estimate of $405.70 million by 2.22 percent.  This is a 71.75 percent increase over sales of $230.97 million the same period last year.</p>


Earnings Misses

VIST

Vista Energy Q2 Sales $396.70M Miss $405.70M Estimate

<p>Scotiabank  analyst Jason Bouvier   maintains Strathcona Resources (TSX:<a class="ticker" href="https://www.benzinga.com/stock/SCR#TSX">SCR</a>) with a Sector Outperform and raises the price target from C$40 to C$42.</p>


Price Target

Analyst Ratings

TSX:SCR

Scotiabank Maintains Sector Outperform on Strathcona Resources, Raises Price Target to C$42

ELME

Elme Communities Entered Into $500M Credit Facility

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>Wall Street loves winners. They enjoy backing stocks that are rising and want to avoid stocks that are falling. Yet rarely do they place a sell rating on a stock.</p>



<p>Whether it is because stocks generally go up over time and a rising tide lifts all boats, or they don&rsquo;t want to miss out on potential fees earned from dealing with a stock sale or other corporate transaction, investors are rarely told to sell any stocks. Out of the thousand of companies that trade on the <strong>NYSE</strong> or <strong>Nasdaq</strong> stock exchanges only a few dozen companies earn the distinction of having a sell rating.</p>



<p>That&rsquo;s where <a href="https://investorplace.com/2024/05/contrarian-bets-3-stocks-wall-street-hates-that-you-should-love/">being a contrarian investor</a> can generate substantial wealth. By fishing in the shallow end of the pond, you can find stocks the market rejects. Trading at deeply discounted prices, you can discover contrarian stocks to buy and make a killing when the inevitable turnaround occurs. Below are three stocks Wall Street has turned its back on that still hold enormous potential for dramatic gains.&nbsp;</p>



<h2>Palantir Technologies (PLTR)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/05/pltr1600-5-300x169.png" alt="In this photo illustration, the Palantir Technologies (PLTR) logo is displayed on a smartphone screen."><div>Source:  rafapress / Shutterstock.com</div></div><p>Artificial intelligence (<strong>AI</strong>) pure-play <strong>Palantir Technologies</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/pltr-stock-quote/"><strong>PLTR</strong></a></span>) is a surprising pick for a stock analysts rate as a sell. Trading under $26 a share, Wall Street put a &ldquo;reduce&rdquo; rating on the stock. It&rsquo;s one of those instances where analysts want to tread lightly and not outright say sell.</p>



<p>You might want to <a href="https://investorplace.com/2024/05/palantir-stock-analysis-should-you-pick-up-pltr-on-the-dip/">dive in head first</a>. Make no mistake, the trepidation around Palantir Technologies is probably related to valuation. The stock isn&rsquo;t cheap. It goes for 188 times earnings and 60 times next year&rsquo;s estimates. The one year consensus price target on the AI stock is $21 a share.</p>



<p>Yet such bloated valuations can occur when a stock is newly profitable. Palantir Technologies only started reporting GAAP profits in late-2022 and has notched six consecutive quarters of being in the black. But having turned profitable, there is no expectation it will reverse course and report losses again.</p>



<p>Palantir Technologies launched its Artificial Intelligence Platform (<strong>AIP</strong>) last year and customers are flocking to it. AIP can <a href="https://investorplace.com/2024/04/the-20-ai-stock-outperforming-nvidia-why-palantir-could-be-the-next-big-thing-in-tech/">integrate data from across organizations</a>, analyze it and package the output into a visually useful product. By the end of 2023, more than <a href="https://investorplace.com/2024/02/pltr-stock-forecast-get-ready-for-another-year-of-dramatic-growth/">560 companies had signed on</a>. This achieved for Palantir Technologies in one quarter what it thought would take at least a year to complete.</p>



<p>Not all analysts think investors should sell. Wedbush Securities analyst Dan Ives is the closest thing we have to a <a href="https://investorplace.com/2024/04/the-20-ai-stock-outperforming-nvidia-why-palantir-could-be-the-next-big-thing-in-tech/">permabull on PLTR stock</a> and he calls it the &ldquo;Messi of AI,&rdquo; referring to the soccer great. That may be some hyperbole, but it underscores the potential the company holds.</p>



<h2>Archer-Daniels-Midland (ADM)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/08/farming-2-300x169.jpg" alt="Image of a tractor cultivating field"><div>Source: Shutterstock</div></div><p>Similarly, grains and oilseed trader <strong>Archer-Daniels-Midland</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/adm-stock-quote/"><strong>ADM</strong></a></span>) has also been labeled a &ldquo;reduce&rdquo; stock. Because it tends to be cyclical, Wall Street understands it will soon swing higher. Rating it a sell wouldn&rsquo;t work for the investment banks.</p>



<p>And ADM is cheap. Unlike Palantir the agriculture stock goes for 10 times trailing earnings and estimates. Also, it trades at a fraction of its sales and a bargain-basement 5x the free cash flow (<strong>FCF</strong>) it produces. Analysts even have a target price implying 12% upside in Archer-Daniels-Midland stock.</p>



<p>So why the sell &mdash; er, reduce &mdash; rating? Commodity prices have plunged from their post-pandemic peak. Even though consumer prices remain elevated, they are well below their 40-year historical highs. A commodities stock amid <a href="https://investorplace.com/2024/06/blue-chip-steals-3-top-tier-stocks-trading-at-bargain-prices/">sliding prices</a> causes consternation amongst analysts.</p>



<p>Yet, the company is moving into new verticals to minimize the volatility in its stock. ADM is expanding its human, pet and animal nutrition business. After a series of mishaps at one of its plants that shut it for most of last year, the facility reopened. Therefore, Archer-Daniels-Midland should soon be swinging higher once more.</p>



<h2>Solventum (SOLV)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/hospital1600-300x169.jpg" alt="Image of a hospital with workers walking in the halls"><div>Source: Shutterstock</div></div><p>The third contrarian stock to buy is <strong>Solventum</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/solv-stock-quote/"><strong>SOLV</strong></a></span>), the healthcare business <strong>3M</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/mmm-stock-quote/"><strong>MMM</strong></a></span>) recently spun off into a standalone company. It is one of the largest providers of sterilization devices, dressings, tapes and other consumables used by healthcare facilities.&nbsp;</p>



<p>Solventum had approximately $8.2 billion in 2023 sales and operates in four business segments. Those include medical surgical, dental solutions, health information systems and purification/filtration. Sales were up in the first quarter as its medical surgical business gained traction. Yet, the stock has lost half its value since being set free.</p>



<p>Undoubtedly the <a href="https://investorplace.com/2024/05/divide-and-conquer-3-stock-spinoffs-set-to-trounce-the-market/">heavy debt 3M saddled Solventum with</a>, some $8.3 billion, plays into Wall Street&rsquo;s reduce rating. However, management says it is determined to pay that amount down over the next two years.</p>



<p>At just nine times earnings estimates, the stock is being discounted by the market. Even the consensus analyst price of almost $66 a share envisions 22% upside in the stock. Thus, investors will want to get in on this contrarian stock to buy before Wall Street wisens up.</p>



<p><em>On the date of publication, Rich Duprey held a LONG position in SOLV and MMM stock. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com <a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/">Publishing Guidelines</a>.</em></p>
<div><p>Rich Duprey has written about stocks and investing for the past 20 years. His articles have appeared on Nasdaq.com, The Motley Fool, and Yahoo! Finance, and he has been referenced by U.S. and international publications, including MarketWatch, Financial Times, Forbes, Fast Company, USA Today, Milwaukee Journal Sentinel, Cheddar News, The Boston Globe, L&rsquo;Express, and numerous other news outlets.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/06/contrarian-plays-3-stocks-to-buy-when-analysts-say-sell/">Contrarian Plays: 3 Stocks to Buy When Analysts Say &#8216;Sell&#8217;</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

Contrarian Plays: 3 Stocks to Buy When Analysts Say 'Sell'

Over the past twelve months, 10 large-cap stocks have underperformed all others. Here's a brief look at these underperforming stocks.

Large-Cap Stocks In Trouble: Here Are The 10 Worst Performers Over The Past 12 Months - Sunday, June 23

Analyst Travis Steed from Bank of America Securities reiterated a Hold rating on Solventum Corporation (SOLV – Research Report) and decreased the p...

Maintaining Hold on Solventum: Navigating Uncertainties in Post-Spinoff Valuation and Long-Term Earnings Outlook

Bottom 10 performing S&P 500 names as H1 looks to close out this week

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>To achieve high returns from the subsequent changes in the market, sharp investors are closely monitoring which top stocks to buy before interest rate cuts as the Federal Reserve considers reducing interest rates. Companies with solid foundations stand to gain much from lower borrowing rates; therefore, finding the greatest investment possibilities in advance is critical. These three exceptional stocks may benefit from a reduction in interest rates.</p>



<p>It is vital to comprehend the significance of these investments. Given that these companies exhibit strong financial performance and strategic expansion goals. These businesses&rsquo; integration of fiber and 5G and aggressive cost-cutting and debt-reduction strategies improve their position in the market. Their great client retention and ongoing expansion of internet services highlight their development potential. In the meantime, they generate a healthy amount of free cash flow and emphasize debt reduction to demonstrate their financial robustness.&nbsp;</p>



<p>In short, the impending interest rate reductions and continuous debt reduction might result in lower interest payments and an improved bottom line, boosting the market value of these stocks.</p>



<h2>AT&amp;T (T)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/t1600c-300x169.jpg" alt="A photo of an AT&amp;T office building."><div>Source: Roman Tiraspolsky / Shutterstock.com</div></div><p><strong>AT&amp;T</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/t-stock-quote/"><strong>T</strong></a></span>) is a telecommunications giant. By combining 5G and fiber technology, AT&amp;T&rsquo;s approach reduces churn and increases net promoter scores, which increases the lifetime value of convergence customers. Differentiating itself from competitors, AT&amp;T is the only provider that can benefit from the owner&rsquo;s economics and scale in both 5G and fiber. Building on the $6 billion in cost reductions realized earlier, AT&amp;T set a new goal to save an additional $2 billion in run-rate costs by&nbsp;<a href="https://investors.att.com/~/media/Files/A/ATT-IR-V2/financial-reports/t-usq-transcript-2024-04-24.pdf" target="_blank">mid-2026.</a>&nbsp;</p>



<p>Additionally, efficiency is the core of controlling expenses and increasing profitability, particularly with rising inflation. Compared to $1 billion in Q1 2023, the company&rsquo;s first-quarter free cash flow <a href="https://about.att.com/story/2024/q1-earnings.html" target="_blank">produced $3.1 billion</a>, a considerable boost. Due to its ability to derive free cash flow, AT&amp;T has reduced its debt. As a result, its net debt-to-adjusted EBITDA ratio&nbsp;<a href="https://about.att.com/story/2024/q1-earnings.html" target="_blank">dropped to 2.9x</a>. Hence, the business is on track to meet its goal of 2.5x by the first half of 2025.&nbsp;</p>



<p>AT&amp;T&rsquo;s strategic cost-saving measures, strong cash flow, and debt reduction position it well on the list of stocks to buy before interest rate cuts.</p>



<h2>Verizon (VZ)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/08/vz-stock-9-300x169.jpg" alt="Verizon Wireless sign and trademark logo."><div>Source: Ken Wolter / Shutterstock.com</div></div><p><strong>Verizon</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/vz-stock-quote/"><strong>VZ</strong></a></span>) has a massive network infrastructure. The yearly improvement in the consumer postpaid phone churn rate was 0.01%, at<a href="https://www.verizon.com/about/news/verizon-begins-2024-strong-wireless-service-revenue-growth-solid-cash-flow-and-continued" target="_blank">&nbsp;0.83%</a>. This low turnover rate reflects happy and devoted customers. In Q1 2024, Verizon added 389,000 new broadband customers, of whom 53,000 were Fios Internet customers. The significant rise in growth can&nbsp;be attributed&nbsp;to the rising demand for high-speed internet services. Hence, 151,000 fixed wireless net additions were made in the business segment, the&nbsp;biggest&nbsp;quarterly performance ever.</p>



<p>Further,&nbsp;<a href="https://www.verizon.com/about/news/verizon-begins-2024-strong-wireless-service-revenue-growth-solid-cash-flow-and-continued" target="_blank">203,000 fixed wireless net additions</a>&nbsp;for customers demonstrate the service&rsquo;s rising popularity. Revenue from fixed wireless access annually increased by approximately $200 million in Q1 to $452 million. This increase highlights the growing income contribution of fixed wireless access to Verizon. As of Q1, net unsecured debt was $126 billion, an increase of $3.7 billion&nbsp;yearly. With this cut, Verizon has more flexibility. Similar to the prior quarter, the net unsecured debt to consolidated adjusted EBITDA ratio was<a href="https://www.verizon.com/about/file/70909/download?token=Q7bcBEuq" target="_blank">&nbsp;2.6 times</a>.&nbsp;</p>



<p>Finally, the company&rsquo;s low churn rates and expanding fixed wireless access revenues support its high mark on the stocks to buy before interest rate cuts list.</p>



<h2>3M (MMM)&nbsp;</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/09/mmm1600g-300x169.jpg" alt="3M logo on top of a corporate building. MMM stock"><div>Source: JPstock / Shutterstock.com</div></div><p><strong>3M</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/mmm-stock-quote/"><strong>MMM</strong></a></span>) is a diversified tech company. With an free cash flow conversion rate of 63%, the business produced an adjusted free cash flow of over&nbsp;<a href="https://d1io3yog0oux5.cloudfront.net/_53aafdd47c748f95c759e205ffa4e72d/3m/db/3222/30862/earnings_release/Q1+2024+Press+Release.pdf" target="_blank">$800 million in the first quarter</a>. This is in line with previous patterns. A 20% decrease from the previous year to $355 million in adjusted capital expenditures in Q1 was reflected in the almost-finished investments in water filtering. 3M had $10.4 billion in net debt, down 13% from Q1 2023, thanks to solid free cash flow creation. During the quarter, the company paid down $2.9 billion in debt, further bolstering its balance sheet.</p>



<p>Moreover, the&nbsp;<a href="https://d1io3yog0oux5.cloudfront.net/_53aafdd47c748f95c759e205ffa4e72d/3m/db/3222/30862/webcast_transcript/Q1+2024+Transcript.pdf" target="_blank">19.9% equity position</a>&nbsp;in <strong>Solventum</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/solv-stock-quote/"><strong>SOLV</strong></a></span>) may offer more liquidity, enabling chances for growth and increased investment. A 13% decrease in net debt and the creation of $800 million in free cash flow demonstrate 3M&rsquo;s strong financial standing and adept handling of obligations. The company&rsquo;s focus on providing value reflects its return of&nbsp;<a href="https://d1io3yog0oux5.cloudfront.net/_53aafdd47c748f95c759e205ffa4e72d/3m/db/3222/30862/earnings_release/Q1+2024+Press+Release.pdf" target="_blank">$835 million to shareholders</a>, with more plans for additional stock repurchases.&nbsp;</p>



<p>3M&rsquo;s focus on returning capital, debt reduction, and strategic investments solidifies its status among the top stocks to buy before interest rate cuts.</p>



<p><em><em>As of this writing, Yiannis Zourmpanos held long positions in T, VZ and MMM. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/">Publishing Guidelines</a></em>.</em></p>
<div><p>Yiannis Zourmpanos is the founder of Yiazou Capital Research, a stock-market research platform designed to elevate the due diligence process through in-depth business analysis.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/06/3-stocks-to-buy-before-the-expected-rate-cut-takes-effect/">3 Stocks to Buy Before the Expected Rate Cut Takes Effect</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

3 Stocks to Buy Before the Expected Rate Cut Takes Effect

Insulet tops S&P 500 growth chart for Q2 as it gains market share in the diabetes space

MediWound jumps amid report of $34 a share takeover offer from Solventum

MediWound jumps amid report of $34 a share takeover offer from Solventum (update)

Solventum: Stumbling Out Of The Gate

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>It is becoming clear that 2024 is a very different year than the last year. Although we&rsquo;re still in the middle of a bull market, it is more of a broad-based rally, higher this time than it was in 2023.</p>



<p>Back then, the so-called Magnificent Seven stocks accounted for <a href="https://investorplace.com/2023/12/wall-street-says-these-3-magnificent-7-stocks-will-crash-in-2024/">virtually all of the market&rsquo;s gains</a>. This year, although most of those companies are still performing well &mdash; and some like <strong>Nvidia</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/nvda-stock-quote/"><strong>NVDA</strong></a></span>) continue to do very well &mdash; the seven tech giants are not having the same impact.&nbsp;</p>



<p>Well, on the <strong>S&amp;P 500</strong> they are, because it is a market capitalization-weighted index. Six of the Magnificent Seven are worth $1 trillion or more (only laggard <strong>Tesla</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/tsla-stock-quote/"><strong>TSLA</strong></a></span>) is not). That means their movements affect the index more than they do a price-weighted index like the <strong>Dow Jones Industrial Average</strong>.</p>



<p>It is also why the S&amp;P 500 is up 17% year-to-date and the Dow is <a href="https://investorplace.com/2024/06/dow-30000-buy-these-3-stocks-now-for-the-coming-dow-crash/">up a measly 4%</a>. Yet this offers investors an opportunity. It suggests undervalued Dow stocks may be more prevalent than those on the popular benchmark index.</p>



<p>So let&rsquo;s dive into the three companies below that may be some of the best undervalued Dow stocks to buy today.</p>



<h2>Goldman Sachs (GS)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/09/gs1600-300x169.png" alt="In this photo illustration the Goldman Sachs Group (GS) logo displayed on a smartphone screen and a stock market graph in the background"><div>Source: rafapress / Shutterstock.com</div></div><p><strong>Goldman Sachs</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/gs-stock-quote/"><strong>GS</strong></a></span>) is an investment bank in transition. Weighed down by acquisitions in wealth management and installment lending that it thought would diversify its operations, today the financial giant is reorganizing its efforts to concentrate on investment banking, trading, and investment management. It will continue divesting consumer-facing businesses.</p>



<p>Goldman took big writedowns on its home improvement lender GreenSky, which it sold last October. It also scrapped its co-branded credit cards with <strong>General Motors</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/gm-stock-quote/"><strong>GM</strong></a></span>) while <strong>Apple</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/aapl-stock-quote/"><strong>AAPL</strong></a></span>) terminated its Goldman Sachs card.</p>



<p>The turnaround effort is working. First-quarter profit exceeded analyst expectations as the investment banking division benefited from increases in underwriting and dealmaking. Last year was a mixed one for mergers and acquisitions. While dealmaking <a href="https://www.spglobal.com/marketintelligence/en/news-insights/latest-news-headlines/european-investment-banks-grow-2023-sector-revenues-as-us-peers-lag-80709205">hit a decade low</a>, some of the biggest acquisitions ever took place, including <strong>Exxon Mobil&rsquo;s</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/xom-stock-quote/"><strong>XOM</strong></a></span>) purchase of Pioneer Natural Resources. Goldman Sachs was the lead advisor on the $60 billion transaction.</p>



<p>The investment banker&rsquo;s stock is up 50% over the past year and Wall Street expects earnings to grow 22% annually for the next five years. Trading at just a fraction to those projected growth rates, Goldman Sachs stock is one of the leading undervalued Dow stocks to buy today.</p>



<h2>3M (MMM)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/09/mmm1600g-300x169.jpg" alt="3M logo on top of a corporate building. MMM stock"><div>Source: JPstock / Shutterstock.com</div></div><p>Industrial conglomerate <strong>3M</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/mmm-stock-quote/"><strong>MMM</strong></a></span>) has destroyed value for investors for years. Over the past decade, the owner of Post-It Notes and Scotch-brand tape has a total return of just 23% compared to a 190% return by the Dow.&nbsp;</p>



<p>Its malaise culminated in May of this year when this former Dividend King slashed its dividend by more than half. Facing mounting lawsuits over faulty products (made by a company it acquired) and environmental pollution allegations, 3M was <a href="https://investorplace.com/2024/06/dow-30000-buy-these-3-stocks-now-for-the-coming-dow-crash/">forced to conserve cash</a>. But it also spun off its consumer products business <strong>Solventum</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/solv-stock-quote/"><strong>SOLV</strong></a></span>) to return some value to shareholders and began settling the lawsuits against it.</p>



<p>Today, 3M is a much healthier company financially and the markets approve. Shares are up 9% in 2024 which turned the conglomerate into an undervalued Dow stock worth buying. 3M goes for 12 times earnings estimates and a deeply discounted 11x free cash flow (<span>FCF</span>). With a lower dividend payment, 3M can now support the payout. MMM stock deserves renewed consideration by investors.</p>



<h2>Dow (DOW)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/09/dow-stock-5-300x169.jpg" alt="DOW Chemical sign outside of a corporate building"><div>Source: JHVEPhoto / Shutterstock.com</div></div><p>This is fun to write: chemical stock <strong>Dow</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/dow-stock-quote/"><strong>DOW</strong></a></span>) is an undervalued Dow stock. Shares trade at 12 times earnings estimates, a fraction of sales and 14x FCF. Dow stock, though, is down 5% this year and off 2% for the last 12 months. Shares remain 27% below the all-time high they hit in 2021.</p>



<p>The tide is turning for the chemicals company. Demand recovered in the first quarter even though sales were down 9% year-over-year. However, they were up 1% sequentially. Chairman and CEO Jim Fitterling told investors, &ldquo;We captured improving demand, maintained pricing, and benefited from lower feedstock and energy costs.&rdquo; As a result, volumes grew and margins expanded.&nbsp;</p>



<p>Because chemicals are a commodity and their price tends to move in tandem with Brent crude oil prices, Dow should benefit from Brent prices north of $84 a barrel. That is 5% above the price one year ago. The Energy Information Administration forecasts oil to trade <a href="https://www.eia.gov/outlooks/steo/">around $89 a barrel</a> in the back half of 2024. It does not expect that to change much next year as it forecasts Brent crude at $88 a barrel.</p>



<p>The higher prices should help Dow improve its capacity utilization. And with lower natural gas prices in the mix now and going forward, the chemicals stock should also benefit as it lowers its feedstock costs. That points to improving profitability and should have investors putting DOW stock on their buy list.</p>



<p><em>On the date of publication, Rich Duprey held a LONG position in MMM, SOLV and XOM stock. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com <a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/">Publishing Guidelines</a>.</em></p>



<p><em>On the date of publication, the responsible editor did not have (either directly or<br>indirectly) any positions in the securities mentioned in this article.</em></p>
<div><p>Rich Duprey has written about stocks and investing for the past 20 years. His articles have appeared on Nasdaq.com, The Motley Fool, and Yahoo! Finance, and he has been referenced by U.S. and international publications, including MarketWatch, Financial Times, Forbes, Fast Company, USA Today, Milwaukee Journal Sentinel, Cheddar News, The Boston Globe, L&rsquo;Express, and numerous other news outlets.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/07/the-3-most-undervalued-dow-stocks-to-buy-in-july-2024/">The 3 Most Undervalued Dow Stocks to Buy in July 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

The 3 Most Undervalued Dow Stocks to Buy in July 2024

AAPL

ALGN

EPAM

ETSY

ILMN

LULU

MDWD

MKTX

MRNA

PAYC

PLTR

PODD

TSLA

VRTX

Press Releases

3M Board of Directors Approves Spin-off of Solventum

GE Vernova and Solventum Set to Join S&P 500; Dentsply Sirona to Join S&P MidCap 400; Others to Join S&P SmallCap 600

Solventum Begins Trading on the New York Stock Exchange

Solventum Names Shirley Edwards to Board of Directors

Solventum Announces First Quarter 2024 Earnings Release Date and Upcoming Investor Events

Solventum Reports First Quarter 2024 Financial Results and Capital Allocation Update

Solventum Cautions Investors Regarding TRC Capital's "Mini-Tender Offer"

Solventum introduces denials prevention solution, an AI-powered tool, empowering health systems to help reduce write-offs and improve top line revenue

The New York Stock Exchange Leads Industry in Global IPO Proceeds for the First Half of 2024

U.S. News & World Report Expands Use of Solventum's Ambulatory Potentially Preventable Complications Grouping Software for Use in Its 2024-2025 Best Hospitals Rankings

Solventum

뉴스

에 대한 최신 뉴스 Solventum (NYSE:SOLV) 주식

월요일, 6월 17, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌